GlassScriptPhysician profile
Stephen D Albano
NPI 1326431594
$3,672.43
in general payments reported to CMS, 2019-2025
10 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.91 · 2021: $181 · 2022: $2,416 · 2023: $825 · 2024: $20.94 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Travel and Lodging: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.75 |
| Travel and Lodging | $196.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,428.33 | 2021-2023 | Mazor X System |
| Globus Medical, INC. | $372.86 | 2023 | Caliber, Creo 5.5, Excelsius3d Imaging System |
| Integrity Implants INC. Dba Accelus | $279.35 | 2023 | |
| Clariance, INC. | $203.76 | 2025 | Erisma-LP |
| Orthofix Medical, INC. | $148.90 | 2023 | Spinal-Stim, Spinal-Stim, Northstar |
| Boston Scientific Corporation | $107.55 | 2021 | |
| Integra Lifesciences Corporation | $84.83 | 2022 | |
| Xtant Medical INC | $20.94 | 2024 | |
| Medtronic USA, INC. | $14.26 | 2020 | |
| Livanova USA, INC. | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Albano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.